XML 46 R39.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Business Combination - Additional Information (Detail)
Aug. 09, 2023
USD ($)
$ / shares
Maximum [Member] | Cash Earnout [Member]  
Business Acquisition [Line Items]  
Contingent liabilities (see Note 9) $ 9,000,000
Maximum [Member] | Common Stock [Member]  
Business Acquisition [Line Items]  
Contingent liabilities (see Note 9) 66,000,000
AxoBio [Member]  
Business Acquisition [Line Items]  
Deferred cash consideration 8,000,000
Transaction costs related to acquisition 1,300,000
Business combination adjusted inventory 8,200,000
Business combination adjusted loan payable $ 502,000
AxoBio [Member] | Trade Name [Member]  
Business Acquisition [Line Items]  
Expected useful life 7 years
AxoBio [Member] | Intellectual Property [Member]  
Business Acquisition [Line Items]  
Expected useful life 7 years
AxoBio [Member] | Maximum [Member] | Cash Earnout [Member]  
Business Acquisition [Line Items]  
Contingent liabilities (see Note 9) $ 9,000,000
AxoBio [Member] | Maximum [Member] | Common Stock [Member]  
Business Acquisition [Line Items]  
Contingent liabilities (see Note 9) $ 66,000,000
Series A Preferred Stock [Member] | AxoBio [Member]  
Business Acquisition [Line Items]  
Estimated fair value per share | $ / shares $ 2,447